4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-028110
CEO and Chairman sold 45,000 shares at an average $35.60 ($1,601,967)
- CEO and Chairman acquired 45,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2020-05-07 | Option exercise | +45,000 | $0.33 | $14,850 | 1,923,180 | D |
| ROBINS CHAD M CEO and Chairman | 2020-05-07 | Sale | −36,186 | $35.47 | $1,283,517 | 1,886,994 | D |
| ROBINS CHAD M CEO and Chairman | 2020-05-07 | Sale | −8,814 | $36.13 | $318,450 | 1,878,180 | D |
| Derivatives | |||||||
| ROBINS CHAD M CEO and Chairman | 2020-05-07 | Option exercise · Stock Option (Right to Buy) | −45,000 | 601,560 | D | ||
| Open-market sales · 45,000 sh · avg $35.60 · $1,601,967 | |||||||
Loading xslF345X03/doc4.xml…